Tech Company Financing Transactions

Madison Vaccines Funding Round

On 12/31/2014, Madison Vaccines announced $4.1 million in financing from private investors and Venture Investors.

Transaction Overview

Company Name
Announced On
12/31/2014
Transaction Type
Venture Equity
Amount
$4,059,000
Round
Undisclosed
Investors

Venture Investors (Paul Weiss)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
505 South Rosa Rd. 201
Madison, WI 53719
USA
Email Address
Not Recorded
Overview
The principal mission of Madison, Wisconsin-based MVI is the development of therapeutic plasmid DNA vaccine products for patients with prostate cancer. MVI is also developing a sensitivity test to identify those patients who will derive clinical benefit from these vaccines.
Profile
Madison Vaccines LinkedIn Company Profile
Social Media
Madison Vaccines Company Twitter Account
Company News
Madison Vaccines News
Facebook
Madison Vaccines on Facebook
YouTube
Madison Vaccines on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Rick Lesniewski
  Rick Lesniewski LinkedIn Profile  Rick Lesniewski Twitter Account  Rick Lesniewski News  Rick Lesniewski on Facebook
Chief Scientific Officer
Douglas McNeel
  Douglas McNeel LinkedIn Profile  Douglas McNeel Twitter Account  Douglas McNeel News  Douglas McNeel on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/31/2014: Quoddy venture capital transaction
Next: 12/31/2014: Seachaid Pharmaceuticals venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on all VC transactions involving tech companies. VC transactions reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary